Concepedia

Andrea Ahnmark

AA

Statistics

Publications

15

Citations

1.1K

H-Index

14

Active since

2005

Affiliations

AstraZeneca (Sweden)(Current)

University of Gothenburg

AstraZeneca (Finland)

AstraZeneca (United Kingdom)

AstraZeneca (Japan)

Andrea Ahnmark is an author at AstraZeneca (Sweden) specializing in life sciences, lipid metabolism, and metabolic regulation.

ORCID

Publications per year

2005–2022

15

Publications

15

Opposing Effects of Adiponectin Receptors 1 and 2 on Energy Metabolism

Mikael Bjursell, Andrea Ahnmark, Mohammad Bohlooly‐Y et al. · Diabetes · 2007 · 280 citations · Full text

, , +17

Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice

Daniel Lindén, Andrea Ahnmark, Piero Pingitore et al. · Molecular Metabolism · 2019 · 210 citations · Full text

, , +12

Liver‐directed overexpression of mitochondrial glycerol‐3‐phosphate acyltransferase results in hepatic steatosis, increased triacylglycerol secretion and reduced fatty acid oxidation

Daniel Lindén, Lena William‐Olsson, Andrea Ahnmark et al. · The FASEB Journal · 2006 · 119 citations

, , +17

PPARα activation increases triglyceride mass and adipose differentiation-related protein in hepatocytes

Ulrika Edvardsson, Anna Ljungberg, Daniel Lindén et al. · Journal of Lipid Research · 2005 · 107 citations · Full text

, , +17

PPARγ and PPARα synergize to induce robust browning of white fat in vivo

Tobias Kroon, Matthew Harms, Stefanie Maurer et al. · Molecular Metabolism · 2020 · 87 citations · Full text

, , +17

1–5 of 15